Publications & Media

The Psychedelic Therapy Alliance and its members contribute to the advancement of psychedelic therapy through research, clinical practice, education, and thought leadership. Explore research, publications, perspectives, and media from the Alliance and our members.

Research

Peer-reviewed research and scholarly publications authored or co-authored by Alliance members, along with resources, guidance, position statements, and other publications produced or contributed to by the Psychedelic Therapy Alliance.

Society of Clinical Psychology, APA Division 12. A Clinician’s Toolkit for Psychedelic-Assisted Therapy. A comprehensive, evidence-informed clinical resource covering scientific foundations, cultural humility, models of care, preparation and integration, safety, harm reduction, ethics, legal considerations, and clinician readiness.

View resource →Clinical PracticeEthicsHarm ReductionPsychedelic-Assisted Therapy

Alpert, M. D., Paleos, C., & Thomas, C. (2026). Inner-Directed Therapy in MDMA-Assisted Psychotherapy. American Journal of Psychiatry, 183(3), 180–182.

View publication →Clinical PracticeMDMAPsychedelic-Assisted Therapy

O’Donnell, K. C., Okano, L., Alpert, M., Nicholas, C. R., Thomas, C., Poulter, B., Mithoefer, A., Mithoefer, M., & Ot’alora G., M. (2024). The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD. Frontiers in Psychology, 15, 1427531.

View publication →Clinical PracticeClinical TrialsMDMAPhase 3PTSD

Mitchell, J. M., et al. (2023). MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine, 29, 2473–2480.

View publication →Clinical TrialsMDMAPhase 3PTSD

Mitchell, J. M., et al. (2021). MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27, 1025–1033.

View publication →Clinical TrialsMDMAPhase 3PTSD

Ot'alora G., M., et al. (2018). 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. Journal of Psychopharmacology, 32, 1295–1307.

View publication →Clinical TrialsMDMAPhase 2PTSD

Mithoefer, M. C., et al. (2018). 3,4-Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry, 5, 486–497.

View publication →Clinical TrialsMDMAPhase 2PTSDVeterans & First Responders

Articles & Perspectives

Articles, essays, commentaries, and other professional publications written by Alliance members.

Articles will be added here soon.

Alliance in the Media

News coverage, interviews, podcasts, and other media featuring the Psychedelic Therapy Alliance.

Media coverage will be added here soon.

Member Media

Selected interviews, podcasts, talks, and media appearances featuring Alliance members.

Member media will be added here soon.